In such actions as resistance training, cardio, or daily activity
doi: 10.6133/apjcn.202103_30(1).0017 13 ChenJJayachandranMBaiWXuB
CV outcomes for adult patients with type 2 diabetes and established cardiovascular disease LEADERa landmark CVOT for Victoza 1 9,340 patients Key inclusion criteria: T2D, A1C 7.0% Age 50 years and established CVD OR Age 60 years and risk factors for CVD Cardiovascular standards of care (antihypertensives, lipid-lowering agents, and antiplatelet therapy) Diabetes standards of care (lifestyle modification, OADs, and insulin) Duration 3.5-5 years Time to first major adverse cardiovascular event (MACE) composed of: Composite primary endpoint CV death Nonfatal MI Nonfatal stroke Prospectively designed and powered to assess noninferiority and then superiority Patients were titrated to maximum tolerated dose of 0.6 mg to 1.8 mg Median daily dose of Victoza was 1.78 mg Victoza significantly reduced MACE in adults with T2D and established CVD 1 Absolute risk reduction: 1.9% Median time of exposure to treatment: 3.5 years
Effect of vitamin E on glutathione-dependent enzymes. Drug Metab Rev
You are evaluating Citizen Meds as a telehealth route to tirzepatide and you want a straight answer on whether the service is legitimate before you hand over a card number
La dosis recomendada de L-Carnitina vara segn la forma en que se presenta el suplemento y los objetivos individuales